Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: Subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials

Clinical and Experimental Metastasis

Volumn 17, Issue 5, 1999, Pages 389-396

  Prest, Sara J ^a   Rees, Robert C ^b   Murdoch, Craig ^c   Marshall, John F ^d   Cooper, Patricia A ^e   Bibby, Michael ^e   Li, Geng ^b   Ali, Selman ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^c SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

^e UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Breast cancer; Chemokine; Integrin; Metastasis; Migration

Indexed keywords

CHEMOKINE; INTEGRIN; RANTES;

ARTICLE; BREAST CARCINOMA; CARCINOMA CELL; CELL DIFFERENTIATION; CELL MIGRATION; CELL STRAIN MCF 7; CELL SUBPOPULATION; CHEMOKINESIS; CHEMOTAXIS; GENETIC HETEROGENEITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VIVO STUDY; PROTEIN FAMILY; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL DIVISION; CHEMOTAXIS; FEMALE; HUMANS; MACROPHAGE INFLAMMATORY PROTEIN-1; RANTES; RECEPTORS, CHEMOKINE; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0033376905     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006657109866     Document Type: Article

References (42)

1. 1. Lopez-Conejo T, Olmo N, Turnay J et al. Characterisation of tumourigenic sub-lines from a poorly tumourigenic human colon adenocarcinoma cell line. Int J Cancer 1996; 67: 668-75.
2. 2. Jacob K, Bosserhoff AK, Wach F et al. Characterisation of selected strongly and weakly invasive sublines of a primary human melanoma cell line and isolation of subtractive cDNA clones. Int J Cancer 1995; 60: 668-75.
3. 3. Nakajima M, Welch DR, Belloni PN, Nicolson GL. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res 1987; 47: 4869-76.
4. 4. Huijzer JC, Uhlenkott CE, Meadows GG. Differences in expression of metalloproteinases and plasminogen activators in murine melanocytes and B16 melanoma variants: Lack of association with in vitro invasion. Int J Cancer 1995; 63: 92-9.
5. 5. Teale DM, Rees RC. Metastatic heterogeneity in a spontaneously metastatic HSV-2 induced hamester fibrosarcoma in association of phenotypic and genotypic with metastatic potential. Invasion Metastasis 1987; 7: 129-143.
6. 6. Yuan XM, Xie FP, Lu ZB et al. The establishment of two cell lines from a mouse uterine cervical carcinoma (U-14) and their metastatic phenotype changes. Clin Exp Met 1995; 13: 463-73.
7. 7. Youngs SJ, Ali SA, Taub DD, Rees RC. Chemokine induced migrational responses in human breast carcinoma cell lines. Int J Cancer 1997; 71: 257-66.
8. 8. Seiber TK, Shafie SM, Triche TJ et al. Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice. Cancer Res 1983; 43: 2223-2239.
9. 9. Holmes WE, Lee J, Kuang WJ et al. Structure and functional expression of a human interleukin-8 receptor. Science 1991; 253: 1278-80.
10. 10. Murphy PM, Tiffany HL. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 1991; 253: 1280-83.
11. 11. Loetscher M, Gerber B, Loetscher P et al. Chemokine receptor specific for IP10 and Mig: Structure, function, and expression in activated T-lymphocytes. J Exp Med 1996; 184: 963-9.
12. 12. Loetscher M, Geiser T, O'Reilly T et al. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J Biol Chem 1994; 269: 232-7.
13. 13. Neote K, Digregorio D, Mak JY et al. Molecular cloning, functional expression, and signalling characteristics of a C-C chemokine receptor. Cell 1993; 72: 415-25.
14. 14. Chario IF, Myers SJ, Herman A et al. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci USA 1994; 91: 2752-6.
15. 15. Daugherty BL, Siciliano SJ, Demartino JA et al. Cloning, expression, and characterisation of the human cosinophil eotaxin receptor. J Exp Med, 1996; 183: 2349-54.
16. 16. Power CA, Meyer A, Nemeth K et al. Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J Biol Chem 1995; 270: 19495-500.
17. 17. Samson M, Labbe O, Mollereau C et al. Molecular cloning and functional expression of a human CC chemokine receptor gene. Biochemistry 1996; 35: 3362-7.
18. 18. Hart IR. The selection and characterisation of an invasive variant of the B16 melanoma. Am J Path 1979; 97: 587-600.
19. 19. Li G, Ali SA, Marshall JF et al. Fibronectin is chemotactic for CT26 colon carcinoma cells: Sub-lines selected for increased chemotaxis to fibronectin display decreased tumourigenicity and lung colonization. Clin Exp Metast 1998; 16: 683-91.
20. 20. Koch AE, Pol Verini PJ, Kunkel SL et al. Interleukin-8 as a macrophage derived mediator of angiogenesis. Science 1992; 258: 1798-801.
21. 21. Cao Y, Chen C, Weatherbee JA et al. Gro-β-a CXC chemokine is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice. J Ex Med 1995; 182: 2069-77.
22. 22. Strieter RM, Polverini PJ, Arenberg DA et al. Role of CXC chemokines as regulators of angiogenesis in lung cancer. Leukocyte Biology, 1995; 57: 752-62.
23. 23. Korfel A, Von Marschal LZ, Koenigsmann M et al. Macrophage inflammatory protein (MIP)-1α/stem cell inhibitor (SCI) does not effect clonal growth of human solid tumour cell lines in vitro. Int J Oncol 1994; 4: 353-7.
24. 24. Hayashi S, Kurdowska A, Cohen AB et al. A synthetic peptide inhibitor for a chemokines inhibits the growth of melanoma cell lines. J Clin Invest 1997; 99: 2581-7.
25. 25. Ben-Baruch A, Xu L, Young PR et al. Monocyte chemotactic protein 3 (MCP 3) interacts with multiple leukocyte receptors. C-CCKRI a receptor for macrophage inflammatory protein I alpha/RANTES is also a functional receptor for MCP3. J Biol Chem 1995; 270: 22123-8.
26. 26. Combadiere C, Ahuja SK, Tiffany HL, Murphy PM. Cloning and functional expression of CC-CKR5 a human monocyte CC chemokine receptor selective for MIP-1α, MIP-1β and RANTES. J Leukocyte Biol 1996; 60, 147-5 2.
27. 27. Raport CJ, Gosling J, Schweickart VL et al. Molecular cloning and functional characterisation of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1β and MIP-1α. J Biol Chem 1996; 271: 17161-6.
28. 28. Schall TJ. Biology of the RANTES/SIS cytokine family. Cytokine 1991; 3: 165-8 3.
29. 29. Zachariae COC. Chemotactic cytokines and inflammation - biological properties of the lymphocyte and monocyte chemotactic factors ELCF, MCAF and IL-8. Acta Dermato Venereologica 1993; S181: 1-37.
30. 30. Graham GJ, Pragnell IB. SCI/MIP-1alpha: A potent stem cell inhibitor with potential roles in development. Dev Biol 1992; 151: 377-8 1.
31. 31. Parkinson EK, Gramham GJ, Daubersies P et al. Hemopoietic stem cell inhibitor (SCI/MIP-1α) also inhibits clongenic epidermal keratinocyte proliferation. J Invest Dermatol 1993; 101: 113-7.
32. 32. Dedhar S, Saulnier R. Alterations in integrin receptor expression on chemically transformed human cells: Specific enhancement of laminin and collagen receptor complexes. J Cell Biol 1990; 110: 481-9.
33. 33. Castronovo V. Laminin receptors and laminin binding proteins during tumour invasion and metastasis. Invasion Matastasis 1993; 13: 1-3 0.
34. 34. Kim WH, Jun SH, Kibbey MC et al. Expression of β1 integrin in laminin adhesion selected human colon cancer cell lines of varying tumourigenicity. Invasion Metastasis 1995; 14: 147-5 5.
35. 35. Fujita S, Watanabe M, Kubota T et al. Alteration of the expression in integrin β1 subunits correlates with invasion and metastasis in colorectal cancer. Cancer Lett 1995; 91: 145-9.
36. 36. Falcioni R, Kennel SJ, Giacomini P et al. Expression of tumour antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice. Cancer Res 1986; 46: 5772-8.
37. 37. Dardenne AJ, Richman PI, Horton MA et al. Co-ordinated expression of the alpha 6 integrin laminin receptor subunit and laminin in breast cancer. J Pathol 1992; 165: 213-2 0.
38. 38. Giancotti FG, Ruoslathi E. Elevated levels of the α5β1 fibronectin receptor suppresses the phenotype of Chinese hamster ovary cells. Cell 1990; 60: 849-5 9.
39. 39. Schreiner C, Fisher M, Hussein S, Juliano RL. Increased tumourigenicity of fibronectin receptor deficient Chinese hamster ovary cell variants. Cancer Res 1991; 51: 1738-4 0.
40. 40. Symington BE. Fibronectin overexpression and loss of transformed phenotype in a stable variant of the K562 cell line. Cell 1990; 1: 637-4 8.
41. 41. Carr MW, Alon R, Springer TA. The CC chemokines MCP-1 differentially modulates the avidity of beta-1 and beta-2 integrins on T-lymphocytes. Immunity 1996; 4: 179-8 7.
42. 42. Weber C, Alon R, Moser B. Springer TA. Sequential regulation of alpha-4-beta-1 and alpha-5-beta-1 integrin avidity by CC chemokines in monocytes-implications for transendothelial chemotaxis. J Cell Biol 1996; 134: 1063-73